Correlation Between Ambrx Biopharma and Elevation Oncology
Can any of the company-specific risk be diversified away by investing in both Ambrx Biopharma and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ambrx Biopharma and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ambrx Biopharma American and Elevation Oncology, you can compare the effects of market volatilities on Ambrx Biopharma and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ambrx Biopharma with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ambrx Biopharma and Elevation Oncology.
Diversification Opportunities for Ambrx Biopharma and Elevation Oncology
-0.32 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Ambrx and Elevation is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Ambrx Biopharma American and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and Ambrx Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ambrx Biopharma American are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of Ambrx Biopharma i.e., Ambrx Biopharma and Elevation Oncology go up and down completely randomly.
Pair Corralation between Ambrx Biopharma and Elevation Oncology
If you would invest 57.00 in Elevation Oncology on September 2, 2024 and sell it today you would earn a total of 7.00 from holding Elevation Oncology or generate 12.28% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 0.4% |
| Values | Daily Returns |
Ambrx Biopharma American vs. Elevation Oncology
Performance |
| Timeline |
| Ambrx Biopharma American |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Elevation Oncology |
Ambrx Biopharma and Elevation Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ambrx Biopharma and Elevation Oncology
The main advantage of trading using opposite Ambrx Biopharma and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ambrx Biopharma position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.| Ambrx Biopharma vs. Immix Biopharma | Ambrx Biopharma vs. Cns Pharmaceuticals | Ambrx Biopharma vs. Sonnet Biotherapeutics Holdings | Ambrx Biopharma vs. Enveric Biosciences |
| Elevation Oncology vs. Ocean Biomedical | Elevation Oncology vs. Zura Bio Limited | Elevation Oncology vs. Enveric Biosciences | Elevation Oncology vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |